Reversible myoclonus‐ataxia encephalitis related to anti‐mGLUR1 autoantibodies

Movement DisordersVolume 34, Issue 3 p. 438-439 Letters: New Observations Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies Cedric Gollion MD, Cedric Gollion MD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceSearch for more papers by this authorJulia Dupouy MD, Julia Dupouy MD Department of Neurology, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorMeryl Roberts MD, Meryl Roberts MD Department of Neurology, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorMarion Simonetta-Moreau MD, PhD, Marion Simonetta-Moreau MD, PhD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceSearch for more papers by this authorChristine Brefel Courbon MD, Christine Brefel Courbon MD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France Department of Clinical Pharmacology, University Hospital, Toulouse, FranceSearch for more papers by this authorOlivier Rascol MD, PhD, Olivier Rascol MD, PhD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France Department of Clinical Pharmacology, University Hospital, Toulouse, FranceSearch for more papers by this authorJerome Honnorat MD, PhD, Jerome Honnorat MD, PhD French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon — Université Claude Bernard Lyon 1, Lyon, FranceSearch for more papers by this authorFabienne Ory Magne MD, Corresponding Author Fabienne Ory Magne MD ory.f@chu-toulouse.fr Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceCorrespondence to: Fabienne Ory-Magne, Inserm U 825, Pavillon Baudot, CHU Purpan, place du Dr Baylac, 31024 Toulouse cedex 3, France; E-mail: ory.f@chu-toulouse.frSearch for more papers by this author Cedric Gollion MD, Cedric Gollion MD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceSearch for more papers by this authorJulia Dupouy MD, Julia Dupouy MD Department of Neurology, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorMeryl Roberts MD, Meryl Roberts MD Department of Neurology, University Hospital of Toulouse, Toulouse, FranceSearch for more papers by this authorMarion Simonetta-Moreau MD, PhD, Marion Simonetta-Moreau MD, PhD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceSearch for more papers by this authorChristine Brefel Courbon MD, Christine Brefel Courbon MD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France Department of Clinical Pharmacology, University Hospital, Toulouse, FranceSearch for more papers by this authorOlivier Rascol MD, PhD, Olivier Rascol MD, PhD Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, France Department of Clinical Pharmacology, University Hospital, Toulouse, FranceSearch for more papers by this authorJerome Honnorat MD, PhD, Jerome Honnorat MD, PhD French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon — Université Claude Bernard Lyon 1, Lyon, FranceSearch for more papers by this authorFabienne Ory Magne MD, Corresponding Author Fabienne Ory Magne MD ory.f@chu-toulouse.fr Department of Neurology, University Hospital of Toulouse, Toulouse, France INSERM, Imagerie Cérébrale et Handicaps Neurologiques, UMR 1214, Toulouse, FranceCorrespondence to: Fabienne Ory-Magne, Inserm U 825, Pavillon Baudot, CHU Purpan, place du Dr Baylac, 31024 Toulouse cedex 3, France; E-mail: ory.f@chu-toulouse.frSearch for more papers by this author First published: 13 February 2019 https://doi.org/10.1002/mds.27634Citations: 4 Relevant conflicts of interests/financial disclosures: Cedric Gollion, Meryl Roberts, and Jerome Honnorat have nothing to report. Julia Dupouy has received grants from Teva. Marion Simonetta-Moreau has received consulting fees from Allergan, Ipsen, and Merz. Christine Brefel-Courbon has received grants from the CHU de Toulouse, France-Parkinson, Programme Hospitalier de Recherche Clinique, fees for serving as an advisory board member for Zambon, and consulting activities from Teva, UCB, Aguettant, AbbVie, and Orkyn. Olivier Rascol has served on the advisory boards or as a consultant for AbbVie, Adamas, Acorda, Addex, AlzProtect, Apopharma, Astrazeneca, Bial, Biogen, Britannia,Clevexel, INC Reasearch, Lundbeck, Lupin, Merck, MundiPharma, Neuratris, Neuroderm, Novartis, Osmotica, Oxford, Biomedica, Parexel, Pfizer, Prexton, Therapeutics, Quintiles, Sanofi, Servier, Sunovion, Théranexus, Takeda, Teva, UCB, XenoPort, and Zambon, and has received grants from the Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, and the European Commission (FP7, H2020). Fabienne Ory Magne has received fees for serving as an advisory board member for AbbVie and Orkyn and for consulting for Zambon, UCB, Aguettant, AbbVie, and Orkyn. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Supporting Information Filename Description mds27634-sup-0001-VideoS1.wmvWindows Media video, 18.5 MB Video S1 Supporting Information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume34, Issue3March 2019Pages 438-439 RelatedInformation